UncategorizedCelularity publishes phase 2 results for PDA-002 in diabetic foot ulcers – Longevity.Technology Empower Meds / October 17, 2025
UncategorizedTransforming CNS drug discovery using ‘reactivated’ human brains Empower Meds / October 16, 2025
UncategorizedFunction Health honored by Goldman Sachs at entrepreneurship summit – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedTelomir reveals preclinical results for Telomir-1 in cell and animal models – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedCortechs.ai acquires ZepMed IP to boost neuroimaging tools – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedCymbiotika arrives at Target in first major retail expansion – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedVasa Therapeutics gains FDA clearance for VS-041 IND – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedMinovia secures orphan drug status for MNV-201 in MDS – Longevity.Technology Empower Meds / October 16, 2025
